Cargando…
Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity
Topoisomerase inhibitors are potent DNA damaging agents which are widely used in oncology, and they demonstrate robust synergistic tumor cell killing in combination with DNA repair inhibitors, including poly(ADP)-ribose polymerase (PARP) inhibitors. However, their use has been severely limited by th...
Autores principales: | Gayle, Sophia, Aiello, Robert, Leelatian, Nalin, Beckta, Jason M, Bechtold, Jane, Bourassa, Patricia, Csengery, Johanna, Maguire, Robert J, Marshall, Dan, Sundaram, Ranjini K, Van Doorn, Jinny, Jones, Kelli, Moore, Hunter, Lopresti-Morrow, Lori, Paradis, Timothy, Tylaska, Laurie, Zhang, Qing, Visca, Hannah, Reshetnyak, Yana K, Andreev, Oleg A, Engelman, Donald M, Glazer, Peter M, Bindra, Ranjit S, Paralkar, Vishwas M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210154/ https://www.ncbi.nlm.nih.gov/pubmed/34316708 http://dx.doi.org/10.1093/narcan/zcab021 |
Ejemplares similares
-
Correction to ‘Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity’
por: Gayle, Sophia, et al.
Publicado: (2021) -
Alkylation of nucleobases by 2-chloro-N,N-diethylethanamine hydrochloride (CDEAH) sensitizes PARP1-deficient tumors
por: Wie, Minwoo, et al.
Publicado: (2023) -
Mouse model and human patient data reveal critical roles for Pten and p53 in suppressing POLE mutant tumor development
por: Park, Vivian S, et al.
Publicado: (2022) -
The hereditary N363K POLE exonuclease mutant extends PPAP tumor spectrum to glioblastomas by causing DNA damage and aneuploidy in addition to increased mismatch mutagenicity
por: Labrousse, Guillaume, et al.
Publicado: (2023) -
Tracking telomere fusions through crisis reveals conflict between DNA transcription and the DNA damage response
por: Liddiard, Kate, et al.
Publicado: (2021)